Elham Behshad

805 total citations
16 papers, 537 citations indexed

About

Elham Behshad is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Elham Behshad has authored 16 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Elham Behshad's work include Protein Degradation and Inhibitors (3 papers), Folate and B Vitamins Research (3 papers) and Metalloenzymes and iron-sulfur proteins (3 papers). Elham Behshad is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Folate and B Vitamins Research (3 papers) and Metalloenzymes and iron-sulfur proteins (3 papers). Elham Behshad collaborates with scholars based in United States, Iran and Cyprus. Elham Behshad's co-authors include J. Martin Bollinger, Perry A. Frey, Sharon Diamond, Richard Wynn, Jason Boer, Eva A. Enns, Catherine L. Drennan, Qian Wang, Yu Li and Wenqing Yao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Elham Behshad

14 papers receiving 530 citations

Peers

Countries citing papers authored by Elham Behshad

Since Specialization

Citations

This map shows the geographic impact of Elham Behshad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Behshad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Behshad more than expected).

Fields of papers citing papers by Elham Behshad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Behshad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Behshad. The network helps show where Elham Behshad may publish in the future.

Co-authorship network of co-authors of Elham Behshad

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Behshad. A scholar is included among the top collaborators of Elham Behshad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Behshad. Elham Behshad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders 2025 ·Journal of Medicinal Chemistry ·(unknown), Harshil Dhruv, Qiaolin Deng, Matthew Tudor, (unknown), Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter P. Orth, Elham Behshad, Corey Strickland, Helai P. Mohammad, Longchuan Bai, Donna McEachern, Shaomeng Wang, Zhihua Sui, E. Scott Priestley	0
2	Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degraders 2025 ·Bioorganic & Medicinal Chemistry Letters ·Xuqing Zhang, Qiaolin Deng, Harshil Dhruv, Matthew Tudor, Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter P. Orth, Elham Behshad, (unknown), Helai P. Mohammad, Zhihua Sui, E. Scott Priestley	1
3	Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders 2024 ·Journal of Medicinal Chemistry ·(unknown), Lalgudi S. Harikrishnan, Guozhang Xu, Debangshu Samanta, José C. Clemente, (unknown), (unknown), Lin Yang, Liyue Huang, Mi Wang, Shaomeng Wang, Qiaolin Deng, Elham Behshad, Rakesh Nagilla, Peter Orth, Cory Rice, Corey Strickland, Helai P. Mohammad, E. Scott Priestley, Zhihua Sui	3
4	Abstract 2656: The selective IKZF2 molecular glue degrader, PVTX-405, counters Treg immune suppression,shows significant tumor growth delay as single agent and synergistic response with immune checkpoint therapies (ICTs) 2024 ·Cancer Research ·Harshil Dhruv, Donna McEachern, Longchuan Bai, Xuqing Zhang, Zhixiang Chen, Rakesh Nagilla, Elham Behshad, Bomie Han, Peter Orth, Rohan Kalyan Rej, Paul D. Kirchhoff, Niu Shin, Larry J. Jolivette, Corey Strickland, Zhihua Sui, (unknown), Shaomeng Wang, Helai P. Mohammad	1
5	Variability in Virulence Gene Prevalence Among Uropathogenic Escherichia coli Isolates: Implications for Understanding UTI Pathogenesis 2023 ·Elham Behshad, (unknown), (unknown), (unknown), (unknown)	0
6	Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors 2022 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Anlai Wang, Ke Zhang, Joshua R. Hummel, Ling Kong, Elham Behshad, Xin He, (unknown), (unknown), Min Ye, Sharon Diamond, Maryanne Covington, Swamy Yeleswaram, Onur Atasoylu, (unknown), Wenqing Yao	8
7	PRs proteins and their mechanism in plants. 2015 ·(unknown), Barat Ali Fakheri, Elham Behshad, (unknown)	12
8	The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy 2014 ·Drug Metabolism and Disposition ·Qiang Zhang, Yan Zhang, Sharon Diamond, Jason Boer, Jennifer J. Harris, Yu Li, Mark Rupar, Elham Behshad, Christine Gardiner, Paul Collier, Phillip Liu, Timothy C. Burn, Richard Wynn, Gregory Hollis, Swamy Yeleswaram	85
9	A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3 2011 ·Clinical Cancer Research ·Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando, Holly K. Koblish, Leslie Hall, Jordan S. Fridman, Elham Behshad, Richard Wynn, Yu Li, Jason Boer, Sharon Diamond, Chunhong He, Meizhong Xu, Jin‐Cong Zhuo, Wenqing Yao, Robert Newton, Peggy Scherle	190
10	Evaluation of Tests for Separability and Symmetry of Spatio-temporal Covariance Function 2011 ·Elham Behshad, Mohsen Mohammadzadeh	2
11	Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase 2010 ·PubMed ·Elham Behshad, Ronald M. Klabe, Alexander R. Margulis, (unknown), Mark Rupar, Paul Collier, (unknown), Gregory Hollis, Timothy C. Burn, Richard Wynn	2
12	Kinetic Analysis of Cysteine Desulfurase CD0387 from Synechocystis sp. PCC 6803: Formation of the Persulfide Intermediate 2009 ·Biochemistry ·Elham Behshad, J. Martin Bollinger	34
13	How an Enzyme Tames Reactive Intermediates: Positioning of the Active-Site Components of Lysine 2,3-Aminomutase during Enzymatic Turnover As Determined by ENDOR Spectroscopy 2006 ·Journal of the American Chemical Society ·Nicholas S. Lees, Dawei Chen, Charles J. Walsby, Elham Behshad, Perry A. Frey, Brian M. Hoffman	30
14	Enantiomeric Free Radicals and Enzymatic Control of Stereochemistry in a Radical Mechanism: The Case of Lysine 2,3-Aminomutases 2006 ·Biochemistry ·Elham Behshad, Frank J. Ruzicka, Steven O. Mansoorabadi, David Y. Chen, George H. Reed, Perry A. Frey	39
15	A locking mechanism preventing radical damage in the absence of substrate, as revealed by the x-ray structure of lysine 5,6-aminomutase 2004 ·Proceedings of the National Academy of Sciences ·(unknown), Elham Behshad, (unknown), Eva A. Enns, Perry A. Frey, Catherine L. Drennan	86
16	Mechanism of Cysteine Desulfurase Slr0387 from Synechocystis sp. PCC 6803: Kinetic Analysis of Cleavage of the Persulfide Intermediate by Chemical Reductants 2004 ·Biochemistry ·Elham Behshad, (unknown), J. Martin Bollinger	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact